CUAMC
BLTE

China Universal Asset Management Company’s Belite Bio BLTE Stock Holding History

China Universal Asset Management Company’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$80K – 506
2025
Q4 		$80K Sell
500
-4,500
-90% -$533K 0.01% 422
2025
Q3 		$370K Buy
+5,000
New +$328K 0.03% 277

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

China Universal Asset Management Company's BLTE Position: Q1 2026 in Review

China Universal Asset Management Company sold out of Belite Bio (BLTE) in Q1 2026, closing a stake of 500 shares — an estimated $80K sold.

China Universal Asset Management Company first reported a position in BLTE in Q3 2025 and held it in 2 quarters. The position peaked at $370K in Q3 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • China Universal Asset Management Company reported no remaining Belite Bio position as of Q1 2026 after selling out during the quarter.
  • China Universal Asset Management Company sold 500 Belite Bio shares in Q1 2026, an estimated $80K.
  • China Universal Asset Management Company first reported a position in Belite Bio in Q3 2025 and held it in 2 quarters.
  • China Universal Asset Management Company's Belite Bio position peaked at $370K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.